$HUM Cashflow Statement | Understand Stock

$HUM

$414.85 -$2.37 (0.57%) Close

$HUM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flow

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on sale of business
Loss (gain) on investment securities, net
Gain on Kindred at Home equity method investment
Equity in net losses
Stock-based compensation
Depreciation
Amortization
Impairment of property and equipment
(Benefit) provision for deferred income taxes
Impairment of indefinite-lived intangible assets
Deferred income taxes
Changes in operating assets and liabilities, net of effect of businesses acquired and dispositions:
Receivables
Other assets
Benefits payable
Other liabilities
Unearned revenues
Other, net
Net cash provided by operating activities
Cash flows from investing activities
Proceeds from sale of business, net
Acquisitions, net of cash and cash equivalents acquired
Purchases of property and equipment
Proceeds from sale of property and equipment
Changes in securities lending collateral receivable
Purchases of investment securities
Proceeds from maturities of investment securities
Proceeds from sales of investment securities
Other
Net cash provided by (used in) investing activities
Cash flows from financing activities
(Payments) receipts from contract deposits, net
Proceeds from issuance of senior notes, net
Repayment of senior notes
(Repayments) proceeds from issuance of commercial paper, net
Proceeds from short-term borrowings
Repayment of short-term borrowings
Proceeds from term loan
Repayment of term loan
Debt issue costs
Common stock repurchases
Dividends paid
Changes in securities lending payable
Changes in rebate factor payable
Change in book overdraft
Proceeds from stock option exercises & other
Other, net
Net cash used in financing activities

Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental cash flow disclosures:
Interest payments
Income tax payments, net
Details of businesses acquired in purchase transactions:
Fair value of assets acquired, net of cash acquired
Less: Fair value of liabilities assumed
Less: Noncontrolling interests acquired
Less: Remeasured existing Kindred at Home equity method investment

Comments